Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bone Biologics Corp. (BBLG)
NASDAQ:BBLG
Holding BBLG?
Track your performance easily
BBLG Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.80 - $4.74
Previous Close$1.03
Volume215.57K
Average Volume (3M)179.57K
Market Cap
$2.61M
Enterprise ValueN/A
Total Cash (Recent Filing)$620.38K
Total Debt (Recent Filing)$7.56M
Price to Earnings (P/E)―
Beta0.30
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.42
Shares Outstanding2,463,534
10 Day Avg. Volume127,969
30 Day Avg. Volume179,575
Standard Deviation0.61
R-Squared0.04
Alpha-0.06
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Bone Biologics News
Options Prices
Currently, No data available
---
Ownership Overview
0.16%
Insiders
0.33%
Mutual Funds
0.02% Other Institutional Investors
99.49% Public Companies and Individual Investors
BBLG FAQ
What was Bone Biologics Corp.’s price range in the past 12 months?
Bone Biologics Corp. lowest stock price was $0.80 and its highest was $4.74 in the past 12 months.
What is Bone Biologics Corp.’s market cap?
Bone Biologics Corp.’s market cap is $2.61M.
When is Bone Biologics Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bone Biologics Corp.’s earnings last quarter?
Currently, no data Available
Is Bone Biologics Corp. overvalued?
According to Wall Street analysts Bone Biologics Corp.’s price is currently Overvalued.
Does Bone Biologics Corp. pay dividends?
Bone Biologics Corp. does not currently pay dividends.
What is Bone Biologics Corp.’s EPS estimate?
Bone Biologics Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bone Biologics Corp. have?
Bone Biologics Corp. has 2,463,534 shares outstanding.
What happened to Bone Biologics Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bone Biologics Corp.?
Currently, no hedge funds are holding shares in BBLG
---
Company Description
Bone Biologics Corp.
Bone Biologics Corp. operates as a medical device company, which engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.
---
Technical Analysis
---